Please login to the form below

Not currently logged in
Email:
Password:

Fycompa

This page shows the latest Fycompa news and features for those working in and with pharma, biotech and healthcare.

Germany planning to table pricing reforms 'by the summer'

Germany planning to table pricing reforms 'by the summer'

Eisai did likewise for its epilepsy treatment Fycompa (perampanel).

Latest news

More from news
Approximately 13 fully matching, plus 11 partially matching documents found.

Latest Intelligence

  • Eisai: Bucking the trend with R&D growth Eisai: Bucking the trend with R&D growth

    by adding a new solid dose global manufacturing line for its anti-epileptic medicine Fycompa. ... Fycompa was the first Eisai-developed epilepsy drug and it's “ a drug we can really differentiate”, says Hendler.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

Theresa Heggie
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
Theresa Heggie talks about the biotech’s 16-year path to market, and the promise of its ‘gene silencing’ medicines...
patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...

Infographics